ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.130
0.00 (0.00%)
At close: Aug 7, 2026, 4:00 PM EDT
1.135
+0.005 (0.44%)
After-hours: Aug 7, 2026, 7:34 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $143.73 million as of August 7, 2026. Its market cap has decreased by -51.48% in one year.
Market Cap
143.73M
Enterprise Value
348.98M
1-Year Change
-51.48%
Ranking
Category
Stock Price
$1.13
ChartMarket Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $143.73M, a decrease of -92.96%. That is a compound annual growth rate of -34.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 143.73M | -67.13% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emergent BioSolutions | 248.29M |
| Organogenesis Holdings | 239.33M |
| SIGA Technologies | 218.76M |
| Lifecore Biomedical | 189.64M |
| Aurora Cannabis | 184.07M |
| Journey Medical | 177.05M |
| Cardiol Therapeutics | 158.54M |
| Organigram Global | 138.38M |